Pulmonx (LUNG) Gross Margin (2019 - 2025)

Pulmonx (LUNG) has 7 years of Gross Margin data on file, last reported at 74.65% in Q3 2025.

• On a quarterly basis, Gross Margin rose 95.0% year-over-year to 74.65% in Q3 2025; TTM through Sep 2025 was 73.3%, a 86.0% decrease from a year earlier, with the FY2024 full-year figure at 74.0%, up 9.0% from the prior year.
• Gross Margin for Q3 2025 stood at 74.65%, up from 72.11% in the prior quarter.
• Over the last five years, Gross Margin for LUNG reached as high as 75.21% in Q1 2022 and fell as low as 71.52% in Q1 2021.
• Historically, Gross Margin has averaged 73.79% across 5 years, with a median of 73.99% in 2021.
• Across the five-year window, Gross Margin soared 4644 bps in 2021 and sank 235 bps in 2023, its largest moves.
• Year by year, Gross Margin stood at 74.78% in 2021, then declined by 3 bps to 72.51% in 2022, then rose by 3 bps to 74.7% in 2023, then retreated by 1 bps to 74.02% in 2024, then climbed by 1 bps to 74.65% in 2025.
• Per Business Quant data, the three most recent Gross Margin figures were 74.65% in Q3 2025, 72.11% in Q2 2025, and 72.51% in Q1 2025.